The appropriate energy supply with glucose in rats treated with Liraglutide ameliorated the cardiac function and metabolism, suggesting that, in heart failure patients with incretins-based therapy, the intake of carbohydrates should be carefully considered [163]. This evidence concerns the gene GCG and heart failure.